Table of Content

Part 1. Introduction
1.1 Market definition
1.2 Key benefits
1.3 Market segment
Part 2. Methodology
2.1 Primary
2.2 Secondary
Part 3. Executive summary

Part 4. Market overview
4.1 Introduction
4.2 Market dynamics
4.2.1 Drivers
4.2.2 Restraints

Part 5. Global market for vaccine by vaccine type
5.1 Recombinant & conjugate vaccines
5.1.1 Market size and forecast
5.2 Live attenuated vaccines
5.2.1 Market size and forecast
5.3 Inactivated vaccines
5.3.1 Market size and forecast
5.4 Toxoid vaccines
5.4.1 Market size and forecast
5.5 Others
5.5.1 Market size and forecast

Part 6. Global market for vaccine by indication
6.1 Diphtheria, pertussis, & tetanus (DTP)
6.1.1 Market size and forecast
6.2 Human papillomavirus (HPV)
6.2.1 Market size and forecast
6.3 Influenza
6.3.1 Market size and forecast
6.4 Measles, mumps, & rubella (MMR)
6.4.1 Market size and forecast
6.5 Meningococcal disease
6.5.1 Market size and forecast
6.6 Pneumococcal disease
6.6.1 Market size and forecast
6.7 Rotavirus
6.7.1 Market size and forecast
6.8 Others
6.8.1 Market size and forecast

Part 7. Global market for vaccine by end user
7.1 Pediatric
7.1.1 Market size and forecast
7.2 Adults
7.2.1 Market size and forecast

Part 8. Global market for vaccine by region
8.1 Asia Pacific
8.1.1 Market size and forecast
8.2 Europe
8.2.1 Market size and forecast
8.3 North America
8.3.1 Market size and forecast
8.4 Rest of the World (RoW)
8.4.1 Market size and forecast

Part 9. Key competitor profiles
9.1 Abbott Laboratories
9.2 AstraZeneca plc
9.3 Bavarian Nordic A/S
9.4 Emergent BioSolutions Inc.
9.5 GlaxoSmithKline plc
9.6 Johnson & Johnson (J&J)
9.7 Merck & Co., Inc.
9.8 Merck & Co., Inc.
9.9 Pfizer Inc.
9.10 Sanofi S.A.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

DISCLAIMER
ABOUT GEN CONSULTING COMPANY